Michael P Dube Insider Profile

4 Followers
Michael P Dube, VP & CAO at Intellia Therapeutics, holds 47.01K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Michael P Dube Sold $2,012 shares of Intellia Therapeutics on Oct 04, 2024 for an estimated value of 38.25K.
tipranks
Michael P Dube

Michael P Dube
Intellia Therapeutics (NTLA)
VP & CAO

Not Ranked
Michael P Dube has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$991K
100.00%
A breakdown of Michael P Dube's holdings

Insider Roles

Intellia Therapeutics
(NTLA)
VP & CAO
Roles that Michael P Dube holds in companies

Most Profitable Insider Trade

Stock:
Intellia Therapeutics
(NTLA)
Rating:Informative Sell
Date:Oct 04, 2024 - Today
Return:-3.20%
The most profitable trade made by Michael P Dube

Michael P Dube's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intellia Therapeutics
Oct 04, 2024
VP & CAO
Informative Sell
38.25K
$991.01K
Success Rate for
NTLA
0 out of 1 profitable transactions on
NTLA
0%
Average Return for
NTLA
Average return per transaction on
NTLA
-3.20%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 03, 2024
Uninformative Buy
$0.00
-
$0.00
Oct 04, 2024
Informative Sell
$38.25K
-
$19.01
-3.20%
List of latest transactions for each holding click on a transaction to see Michael P Dube's performance on stock

Michael P Dube insider profile FAQ

What is the percentage of profitable transactions made by Michael P Dube?
The percentage of profitable transactions made by Michael P Dube is ―.
    What is the average return per transaction made by Michael P Dube?
    The average return per transaction made by Michael P Dube is ―.
      What stocks does Michael P Dube hold?
      Michael P Dube holds: NTLA stocks.
        What was Michael P Dube’s latest transaction?
        Michael P Dube latest transaction was an Informative Sell of $38.25K.
          What was Michael P Dube's most profitable transaction?
          Michael P Dube’s most profitable transaction was an Informative Sell of NTLA stock on October 4, 2024. The return on the trade was -3.20%.
            What is Michael P Dube's role in Intellia Therapeutics?
            Michael P Dube's role in Intellia Therapeutics is VP & CAO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.